Skip to main content

Key Product Details

Species Reactivity

Human

Applications

ELISA

Label

DyLight 755 (Excitation = 754 nm, Emission = 776 nm)

Antibody Source

Monoclonal Mouse IgG2b Kappa Clone # RNLS/1940

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

Recombinant human Renalase protein fragment (around aa 34-235) (exact sequence is proprietary) (Uniprot: Q5VYX0)

Localization

Secreted

Marker

Renal Cell Marker

Clonality

Monoclonal

Host

Mouse

Isotype

IgG2b Kappa

Applications for Renalase Antibody (RNLS/1940) [DyLight 755]

Application
Recommended Usage

ELISA

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Protein A or G purified

Formulation

50mM Sodium Borate

Preservative

0.05% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: Renalase

Renalase is a flavin adenine dinucleotide-dependent amine oxidase that is secreted into the blood from the kidney (Xu et al., 2005).[supplied by OMIM]

Alternate Names

C10orf59, RNLS

Gene Symbol

RNLS

Additional Renalase Products

Product Documents for Renalase Antibody (RNLS/1940) [DyLight 755]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for Renalase Antibody (RNLS/1940) [DyLight 755]



DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...